Edgewise Therapeutics, Inc.
NASDAQ:EWTX
27.72 (USD) • At close January 3, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||||||
| Current Assets: | |||||||||||||||||
| Cash & Cash Equivalents
| 44.806 | 43.485 | 30.264 | 86.097 | 32.957 | 31.807 | 48.23 | 21.993 | 109.747 | 18.341 | 34.453 | 15.566 | 10.571 | 50.404 | 221.036 | 104.916 | -23.653 |
| Short Term Investments
| 447.73 | 468.266 | 502.495 | 232.296 | 256.74 | 278.121 | 279.722 | 329.954 | 255.075 | 230.054 | 231.38 | 265.223 | 279.913 | 248.747 | 88.835 | 24.178 | 47.306 |
| Cash and Short Term Investments
| 492.536 | 511.751 | 532.759 | 318.393 | 289.697 | 309.928 | 327.952 | 351.947 | 364.822 | 248.395 | 265.833 | 280.789 | 290.484 | 299.151 | 309.871 | 129.094 | 23.653 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 6.9 | 7.69 | 8.668 | 8.604 | 8.224 | 7.069 | 5.411 | 10.104 | 10.634 | 9.896 | 2.784 | 5.968 | 5.516 | 7.636 | 1.348 | 0.551 | 0 |
| Total Current Assets
| 499.436 | 519.441 | 541.427 | 326.997 | 297.921 | 316.997 | 327.952 | 356.999 | 370.139 | 253.343 | 268.617 | 283.773 | 293.242 | 302.969 | 310.545 | 129.645 | 23.653 |
| Non-Current Assets: | |||||||||||||||||
| Property, Plant & Equipment, Net
| 11.584 | 11.944 | 12.379 | 12.69 | 12.976 | 13.209 | 12.786 | 9.851 | 6.75 | 3.609 | 3.569 | 0.912 | 0.911 | 0.524 | 0.499 | 0.516 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.262 | 0.262 | 0 | 0.348 | 0.467 | 0.419 | 5.662 | 0.251 | 0.264 | 0.447 | 0.559 | 0.548 | 0.295 | 0 | 0.201 | 0.975 | -23.653 |
| Total Non-Current Assets
| 11.846 | 12.206 | 12.379 | 13.038 | 13.443 | 13.628 | 18.448 | 10.102 | 7.014 | 4.056 | 4.128 | 1.46 | 1.206 | 0.524 | 0.7 | 1.491 | -23.653 |
| Total Assets
| 511.282 | 531.647 | 553.806 | 340.035 | 311.364 | 330.625 | 346.4 | 367.101 | 377.153 | 257.399 | 272.745 | 285.233 | 294.448 | 303.493 | 311.245 | 131.136 | 0 |
| Liabilities & Equity: | |||||||||||||||||
| Current Liabilities: | |||||||||||||||||
| Account Payables
| 5.649 | 6.801 | 4.723 | 4.025 | 5.318 | 3.781 | 3.875 | 6.105 | 5.757 | 2.828 | 5.34 | 3.843 | 2.292 | 2.816 | 1.621 | 1.58 | 0 |
| Short Term Debt
| 0.992 | 1.976 | 0.984 | 1.96 | 1.862 | 1.744 | 0.797 | 1.216 | 0.425 | 0.208 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | -0.988 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 12.316 | 8.399 | 8.893 | 10.786 | 9.158 | 8.875 | 8.043 | 9.264 | 7.121 | 6.18 | 4.664 | 6.678 | 6.462 | 3.923 | 3.23 | 2.762 | 0 |
| Total Current Liabilities
| 18.957 | 17.176 | 14.6 | 16.771 | 16.338 | 14.4 | 12.715 | 16.585 | 13.303 | 9.216 | 10.004 | 10.521 | 8.754 | 6.739 | 4.851 | 4.342 | 0 |
| Non-Current Liabilities: | |||||||||||||||||
| Long Term Debt
| 3.448 | 3.997 | 4.265 | 4.434 | 4.599 | 4.77 | 4.845 | 3.8 | 2.446 | 1.636 | 2.198 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.192 | 0.187 | 0.329 | 0.295 | 0 | 0 | 160.214 | 0 |
| Total Non-Current Liabilities
| 3.448 | 3.997 | 4.265 | 4.434 | 4.599 | 4.77 | 4.845 | 3.8 | 2.446 | 1.828 | 2.385 | 0.329 | 0.295 | 0 | 0 | 160.214 | 0 |
| Total Liabilities
| 22.405 | 21.173 | 18.865 | 21.205 | 20.937 | 19.17 | 17.56 | 20.385 | 15.749 | 11.044 | 12.389 | 10.85 | 9.049 | 6.739 | 4.851 | 164.556 | 0 |
| Equity: | |||||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 294.448 | 0.005 | 311.245 | 160.214 | 40.262 |
| Common Stock
| 0.009 | 0.009 | 0.009 | 0.007 | 0.006 | 0.006 | 0.006 | 0.006 | 0.006 | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 | 0 | 0 |
| Retained Earnings
| -338.914 | -304.785 | -273.288 | -244.763 | -214.62 | -188.907 | -167.438 | -144.6 | -125.185 | -107.687 | -91.62 | -76.96 | -64.264 | -51.315 | -40.962 | -34.147 | 0 |
| Accumulated Other Comprehensive Income/Loss
| 1.051 | -1.054 | -0.861 | 0.099 | -0.424 | -0.547 | -0.251 | -1.355 | -2.179 | -2.336 | -1.932 | -0.514 | -0.024 | -0.033 | -0.054 | 0 | -16.853 |
| Other Total Stockholders Equity
| 826.731 | 816.304 | 809.081 | 563.487 | 505.465 | 500.903 | 496.523 | 492.665 | 488.762 | 356.373 | 353.903 | 351.852 | 349.682 | 348.097 | 347.405 | -159.487 | 0 |
| Total Shareholders Equity
| 488.877 | 510.474 | 534.941 | 318.83 | 290.427 | 311.455 | 328.84 | 346.716 | 361.404 | 246.355 | 260.356 | 274.383 | 285.399 | 296.754 | 306.394 | -33.42 | 23.409 |
| Total Equity
| 488.877 | 510.474 | 534.941 | 318.83 | 290.427 | 311.455 | 328.84 | 346.716 | 361.404 | 246.355 | 260.356 | 274.383 | 285.399 | 296.754 | 306.394 | -33.42 | 23.409 |
| Total Liabilities & Shareholders Equity
| 511.282 | 531.647 | 553.806 | 340.035 | 311.364 | 330.625 | 346.4 | 367.101 | 377.153 | 257.399 | 272.745 | 285.233 | 294.448 | 303.493 | 311.245 | 131.136 | 23.409 |